Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lornamead

This article was originally published in The Rose Sheet

Executive Summary

George Russell tapped CEO for company's North American division, following firm's recent acquisition of the Finesse and Aqua Net brands from Unilever, Lornamead Group announces June 7. Reporting to CEO of Lornamead Group Mike Jatania, Russell will oversee company's product development, manufacturing, distribution and marketing activities in North America, Central and South America, firm notes. Among his goals for the division, Russell notes he will guide the company in reinvesting in and reinvigorating the already well-established hair care brands, and will look for opportunities to acquire additional brands. Lornamead recently stated it hopes to build a $500 mil. personal care business in North America in the next three to five years (1"The Rose Sheet" May 15, 2006, In Brief)...

You may also be interested in...



Lornamead

UK company aims to build approximately $500 mil. personal care business in North America in the next three to five years, CEO Mike Jatania says, noting segment is now in excess of $100 mil. with the recent acquisition of Finesse and Aqua Net (1"The Rose Sheet" May 8, 2006, p. 6). In the next 60 days, Lornamead will consult with retailers, conduct focus groups and appoint public relations and advertising agencies to develop its marketing program for the brands, according to Jatania. In November, firm will launch new products under Yardley personal care brand, which was acquired from Procter & Gamble last year, exec adds. Company also markets Natural White teeth whitening products and Lypsyl lip balm...

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel